摘要
【摘要】特发性肺纤维化是一种慢性进展性疤痕性疾病,预后差。部分患者可以出现急性加重,导致病情迅速恶化死亡。特发性肺纤维化急性加重(AE-IPF)发生的原因及发病机制未明,对于AE-IPF的定义和诊断标准也不断地更新,治疗措施有限。本文将对AE-IPF的发病机制、定义、临床特征、诊断标准和治疗手段的研究进展作一综述。
Idiopathic pulmonary fibrosis is a chronic, progressive and scaring disease with a poor prognosis. Some patients will experience acute exacerbation and rapid deterioration and die. The etiology and pathogenesis of acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) are still unclear. The definition and diagnostic criteria of AE-IPF were updated recently. There is no special effective treatment for AE-IPF till now. This article reviews the research advances in pathogenesis, definition, clinical manifestation, diagnostic criteria and treatment of AE IPF.
作者
盛健
陆菊
顾佩玉
汪丽静
曹孟淑
Sheng Jian;Lu Ju;Gu Peiyu;Wang Lijing;Cao Mengshu(Department of Respiratory Medicine, Nanjing Drum Tower Hospital affiliated to Nanjing University Medical School, Nanjing 210008, China)
出处
《国际呼吸杂志》
2018年第1期68-74,共7页
International Journal of Respiration
基金
国家自然科学基金面上项目(81670059)
国家自然科学基金青年基金项目(81200049)
南京市医学科技发展资金(QRX17005)
关键词
特发性肺纤维化
急性加重
Idiopathic pulmonary fibrosis
Acute exacerbation